Why Humana Inc. (HUM) Stock Rose 11.6% on Oct 9, 2026
What happened
Humana surged 11.84% after the Centers for Medicare & Medicaid Services released its final 2027 Medicare Advantage Star Ratings, showing 95% of HUM's Medicare Advantage members will be in 4-star or higher plans—a dramatic jump from 20% in 2026 (Reuters, Yahoo Finance). The company's flagship H5216 contract recovered to 4 stars from 3.5 stars, restoring eligibility for quality bonus payments affecting ~2.4 million members. Analyst Baird upgraded HUM from Neutral to Outperform and raised its price target to $596.
Humana earnings on 2026-11-04 (consensus EPS estimate −$0.90, date not yet confirmed)—likely to update 2027 revenue and earnings guidance based on star-rating monetization.
Other developments that session
Humana Inc. (HUM) filed a new 8-K on October 9, 2026. The specific contents of the filing were not detailed in available sources.
Humana improved Medicare Advantage quality ratings for 2027, with 95% of members in 4-star-or-better plans.
Frequently asked questions
Why did Humana Inc. (HUM) stock rise on Oct 9, 2026?
Humana surged 11.84% after the Centers for Medicare & Medicaid Services released its final 2027 Medicare Advantage Star Ratings, showing 95% of HUM's Medicare Advantage members will be in 4-star or higher plans—a dramatic jump from 20% in 2026 (Reuters, Yahoo Finance). The company's flagship H5216 contract recovered to 4 stars from 3.5 stars, restoring eligibility for quality bonus payments affecting ~2.4 million members. Analyst Baird upgraded HUM from Neutral to Outperform and raised its price target to $596.
How much did HUM stock rise on Oct 9, 2026?
HUM rose 11.6% during the Oct 9, 2026 trading session.